National Psoriasis Foundation   Report issue

Academic/Hospital Phase 4
Founded: Portland OR United States (1967)

Organization Overview

First Clinical Trial
2010
NCT01123265
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

National Psoriasis Foundation